The LILRB3 protein is thought to ameliorate inflammatory responses and limit autoreactivity by binding to MHC class I molecules on antigen-presenting cells and might confer a survival advantage when upregulated, and the PDGFL protein has tumor suppression properties. This evidence concerns the gene LILRB3 and neoplasm.